<SEC-DOCUMENT>0001193125-25-305951.txt : 20251203
<SEC-HEADER>0001193125-25-305951.hdr.sgml : 20251203
<ACCEPTANCE-DATETIME>20251203065643
ACCESSION NUMBER:		0001193125-25-305951
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20251203
FILED AS OF DATE:		20251203
DATE AS OF CHANGE:		20251203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pharvaris N.V.
		CENTRAL INDEX KEY:			0001830487
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40010
		FILM NUMBER:		251544968

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		J.H. OORTWEG 21
		STREET 2:		2333 CH LEIDEN
		CITY:			LEIDEN
		PROVINCE COUNTRY:   	P7
		BUSINESS PHONE:		31 (0)71 203 6410

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		J.H. OORTWEG 21
		STREET 2:		2333 CH LEIDEN
		CITY:			LEIDEN
		PROVINCE COUNTRY:   	P7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pharvaris, B.V.
		DATE OF NAME CHANGE:	20201029
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d69798d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 6-K </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13A-16</FONT> OR <FONT STYLE="white-space:nowrap">15D-16</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of December 2025 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-40010</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Pharvaris N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#8217;s name into English) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Emmy Noetherweg 2 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2333
BK Leiden </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-F.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form <FONT STYLE="white-space:nowrap">20-F&#8194;&#9746;&#8195;&#8195;&#8195;&#8195;Form</FONT> <FONT
STYLE="white-space:nowrap">40-F&#8194;&#9744;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form
<FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Note: Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1) only permits the submission in paper of a Form
<FONT STYLE="white-space:nowrap">6-K</FONT> if submitted solely to provide an attached annual report to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the
registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Note: Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7) only permits the submission in paper of a Form
<FONT STYLE="white-space:nowrap">6-K</FONT> if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant&#8217;s &#8220;home country&#8221;), or under the rules of the home country exchange on which the registrant&#8217;s securities are traded, as long as the report or other document is not a press
release, is not required to be and has not been distributed to the registrant&#8217;s security holders, and, if discussing a material event, has already been the subject of a Form <FONT STYLE="white-space:nowrap">6-K</FONT> submission or other
Commission filing on EDGAR. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PHARVARIS N.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;3, 2025, Pharvaris N.V. issued a press release announcing positive topline data from the <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT>
pivotal study. A copy of the press release is attached hereto as Exhibit 99.1. Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d69798dex991.htm">Press Release, dated December&nbsp;3, 2025. </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>PHARVARIS N.V.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: December 3, 2025</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Berndt Modig</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Berndt Modig</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d69798dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pharvaris Announces Positive Topline Data from <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> Pivotal
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Study Confirming Potential of Deucrictibant for <FONT STYLE="white-space:nowrap">On-Demand</FONT> Treatment of HAE Attacks </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Primary endpoint met; median time to onset of symptom relief achieved in <B>1.28 hours</B>, significantly faster
versus placebo (p&lt;0.0001) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All secondary efficacy endpoints met (p&lt;0.0001), including End of Progression<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP><SUP STYLE="font-size:75%; vertical-align:top">1</SUP> (median <B>17.47 minutes</B>)<B> </B>and complete symptom resolution (median <B>11.95 hours</B>) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Well-tolerated safety profile of deucrictibant confirmed </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Efficacy and safety outcomes consistent across all HAE subtypes represented (HAE type 1, HAE type 2, and HAE with
normal C1 inhibitor) and varying attack severities and locations </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pharvaris to host a conference call and webcast today at 8:00 a.m. EST </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ZUG, Switzerland, December&nbsp;3, 2025 &#8211; Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor
antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency <FONT STYLE="white-space:nowrap">(AAE-C1INH),</FONT> today announced
<FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> pivotal data confirming the potential of deucrictibant&#8217;s differentiated profile for the <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of HAE attacks. The data from Pharvaris&#8217;
first pivotal Phase 3 study will serve as the basis for marketing authorization applications, which are planned to be filed starting in the first half of 2026. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> Study Design and Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> (<U>NCT06343779</U>) global Phase 3, placebo-controlled study evaluated orally administered deucrictibant
immediate-release (IR) capsule (20 mg) for the <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of attacks in people 12 years and older with HAE. The study enrolled a total of 134 participants from 24 countries on six continents. The
patient population studied included adolescents and adults; participants on and not on long-term prophylaxis (LTP); people with HAE type 1, HAE type 2, and HAE with normal C1 inhibitor; and attacks studied included those of varying severities and
across all body locations. This makes this participant population the most representative and, based on prespecified endpoints, the <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> study the first-ever
<FONT STYLE="white-space:nowrap">on-demand</FONT> HAE study to be fully compliant with the Core Outcome Set recommended in the AURORA consensus.<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> The primary endpoint and all 11 secondary efficacy
endpoints, assessed sequentially under a multiplicity-control procedure, achieved statistical significance. </P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term End of Progression is a registered trademark of Pharvaris GmbH. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Petersen RS, et al. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema. J Allergy Clin
Immunol Pract. 2024;12(6):1614-1621. doi:10.1016/j.jaip.2024.04.007. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compared to placebo, deucrictibant demonstrated compelling and differentiating efficacy: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Faster</B> median time to onset of treatment response: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Time to onset of symptom relief by <FONT STYLE="white-space:nowrap">PGI-C</FONT><SUP
STYLE="font-size:75%; vertical-align:top">3</SUP> at least &#8220;a little better&#8221;: <B>1.28 hours</B> versus &gt;12 hours (p&lt;0.0001) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Time to End of Progression<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>: <B>17.47 minutes</B>
versus 228.67 minutes (p&lt;0.0001) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Shorter </B>median time to substantial symptom relief: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Time to substantial symptom relief by <FONT STYLE="white-space:nowrap">PGI-C</FONT> at least
&#8220;better&#8221;: <B>2.85 hours </B>versus &gt;12 hours (p&lt;0.0001) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Time to substantial symptom relief by <FONT STYLE="white-space:nowrap">PGI-S</FONT><SUP
STYLE="font-size:75%; vertical-align:top">4</SUP> <FONT STYLE="white-space:nowrap">&#8805;1-level</FONT> improvement:<B> 2.41 hours</B> versus &gt;12 hours (p&lt;0.0001) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Earlier </B>complete symptom resolution: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Median time to complete symptom resolution by <FONT STYLE="white-space:nowrap">PGI-S</FONT> &#8220;none&#8221;:
<B>11.95 hours</B> versus &gt;24 hours (p&lt;0.0001) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Fewer</B> attacks treated with second dose or rescue medication within 12 hours: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>83.0%</B> of attacks were treated with a single capsule of deucrictibant IR </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>93.2%</B> of deucrictibant-treated attacks were treated without use of rescue medication
</P></TD></TR></TABLE><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">PGI-C:</FONT> Patient Global Impression of Change </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">PGI-S:</FONT> Patient Global Impression of Severity </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203081828490.jpg" ALT="LOGO" STYLE="width:7.18889in;height:3.97708in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marc A. Riedl, M.D., M.S., Professor of Medicine, Clinical Director of the U.S. Hereditary Angioedema Association (HAEA)
Angioedema Center at the University of California San Diego (UCSD), and principal investigator in the <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> study, commented, &#8220;Bradykinin B2 receptor antagonism is a proven and effective mechanism for
treatment of bradykinin-mediated angioedema. Injectable and oral <FONT STYLE="white-space:nowrap">on-demand</FONT> therapies for HAE are available, however unmet medical needs remain. Effective, well-tolerated, and convenient acute treatment is an
essential part of all HAE management plans due to unpredictable angioedema symptoms. The comprehensive and compelling outcomes of <FONT STYLE="white-space:nowrap">RAPIDe-3,</FONT> specifically the fast treatment response and early complete symptom
resolution, demonstrate the potential benefits of deucrictibant as an important <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment for people living with HAE.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peng Lu, M.D., Ph.D., Chief Medical Officer of Pharvaris, stated, &#8220;I would like to sincerely thank the clinical study participants and their caregivers,
the site investigators and staff, our study partners, the HAE community, and the Pharvaris team for their contributions to the <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> study. Together, we carefully designed and rigorously executed a study
evaluating deucrictibant&#8217;s ability to effectively address the unmet needs and high expectations of physicians, regulators, payers, and, most importantly, people living with HAE.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Lu continued, &#8220;These clinically meaningful and statistically significant results demonstrate deucrictibant&#8217;s early-onset treatment
response, fast symptom relief and resolution, and well-tolerated safety profile. This is an important step toward realizing deucrictibant&#8217;s potential to offer control of bradykinin-mediated angioedema attacks. With these data in hand, our team
is working diligently to prepare for regulatory filings to enable access to this promising therapy.&#8221; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Berndt Modig, Chief Executive Officer of Pharvaris, added &#8220;Since its founding, Pharvaris has spent the
last decade pioneering science for patient choice. Deucrictibant combines the proven and effective mechanism of bradykinin B2 receptor antagonism in HAE with the convenience of oral administration. We are thrilled that
<FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> confirmed the profile of deucrictibant IR capsule established in Phase 2. If the <FONT STYLE="white-space:nowrap">CHAPTER-3</FONT> pivotal Phase 3 study confirms deucrictibant extended-release tablet
as a long-term prophylactic of HAE attacks, deucrictibant could be the first and only oral therapy to offer control in both the <FONT STYLE="white-space:nowrap">on-demand</FONT> and prophylactic treatment of bradykinin-mediated angioedema
attacks.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In <FONT STYLE="white-space:nowrap">RAPIDe-3,</FONT> deucrictibant was well tolerated with no treatment-related serious adverse events
and no participants discontinuing treatment due to treatment-emergent adverse events. To date, the safety and tolerability profile was consistent with completed and ongoing studies of deucrictibant for the treatment of HAE attacks with no safety
signals identified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An open-label extension of deucrictibant for the <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of HAE attacks, <FONT
STYLE="white-space:nowrap">RAPIDe-2</FONT> Part B, is ongoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pharvaris plans to present additional efficacy, safety, and patient experience data at
upcoming medical congresses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pharvaris remains on track to submit a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) in the
first half of 2026 for the <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of acute attacks of HAE. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pharvaris will host a live conference call and webcast to discuss the <FONT STYLE="white-space:nowrap">RAPIDe-3</FONT> study topline data in greater detail at
8:00 a.m. EST today via a live webcast; presentation slides may be accessed on the &#8220;<U>Events and Presentations</U>&#8221; page of the Pharvaris investor relations website. Participants interested in asking a verbal question during the Q&amp;A
may do so in the live conference call. An archived replay will also be available on the website for 90 days following the event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Deucrictibant </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deucrictibant is a novel, potent, orally bioavailable small-molecule bradykinin B2 receptor antagonist currently in clinical development. Deucrictibant is
being investigated for its potential to prevent the occurrence of bradykinin-mediated angioedema attacks and to treat the manifestations of attacks if/when they occur by inhibiting bradykinin signaling through the bradykinin B2 receptor. Pharvaris
is developing two formulations of deucrictibant for oral administration: an extended-release tablet to enable sustained absorption and efficacy as prophylactic treatment, and an immediate-release capsule to enable rapid onset of activity for <FONT
STYLE="white-space:nowrap">on-demand</FONT> treatment. Deucrictibant has been granted orphan drug designation for the treatment of bradykinin-mediated angioedema by the U.S. Food and Drug Administration, the European Commission, and Swissmedic. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Pharvaris </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pharvaris is a late-stage
biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs in bradykinin-mediated conditions, including all types of bradykinin-mediated angioedema. Pharvaris&#8217; aspiration is to offer
therapies with injectable-like efficacy<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, a well-tolerated profile, and the convenience of oral administration to prevent and treat bradykinin-mediated angioedema attacks. By delivering on
this aspiration, Pharvaris aims to provide a new standard of care in bradykinin-mediated angioedema. Pharvaris is preparing global marketing authorization applications for deucrictibant immediate-release capsule as an
<FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of HAE attacks, and a global pivotal Phase 3 study of deucrictibant extended-release tablet for the prevention of HAE attacks <FONT STYLE="white-space:nowrap">(CHAPTER-3)</FONT> is ongoing
with topline data anticipated in the second half of 2026. In addition, CREAATE is an ongoing Phase 3 study of deucrictibant for the prophylactic and <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of
<FONT STYLE="white-space:nowrap">AAE-C1INH.</FONT> For more information, visit&nbsp;<U>https://pharvaris.com</U>/. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward Looking Statements
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains certain forward-looking statements that involve substantial risks and uncertainties. All statements contained in this
press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements relating to our future plans, studies and trials, and any statements containing the words
&#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;will,&#8221; &#8220;intend&#8221; and similar expressions. These
forward-looking statements are based on management&#8217;s current expectations, are neither promises nor guarantees, and involve known and unknown risks, uncertainties and other important factors that may cause Pharvaris&#8217; actual results,
performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements. Such risks include but are not limited to the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
following: uncertainty in the outcome of our interactions with regulatory authorities, including the FDA; the expected timing, progress, or success of our clinical development programs,
especially for deucrictibant immediate-release capsules and deucrictibant extended-release tablets, which are in late-stage global clinical trials; our ability to replicate the efficacy and safety demonstrated in the
<FONT STYLE="white-space:nowrap">RAPIDe-1,</FONT> <FONT STYLE="white-space:nowrap">RAPIDe-2,</FONT> <FONT STYLE="white-space:nowrap">RAPIDe-3,</FONT> and <FONT STYLE="white-space:nowrap">CHAPTER-1</FONT> Phase 2 and Phase 3 studies in ongoing and
future nonclinical studies and clinical trials, such as <FONT STYLE="white-space:nowrap">CHAPTER-3,</FONT> and CREAATE; the timing and outcome of regulatory approvals, including the timing and outcome of our planned submission of an NDA with the FDA
in the first half of 2026 for the <FONT STYLE="white-space:nowrap">on-demand</FONT> treatment of acute attacks of HAE; risks arising from epidemic diseases, which may adversely impact our business, nonclinical studies, and clinical trials; our
ability to potentially use deucrictibant for alternative purposes, for example to treat <FONT STYLE="white-space:nowrap">C1-INH</FONT> deficiency <FONT STYLE="white-space:nowrap">(AAE-C1INH);</FONT> the value of our ordinary shares; the timing,
costs and other limitations involved in obtaining regulatory approval for our product candidates, or any other product candidate that we may develop in the future; our ability to establish commercial capabilities or enter into agreements with third
parties to market, sell, and distribute our product candidates; our ability to compete in the pharmaceutical industry, including with respect to existing therapies, emerging potentially competitive therapies and with competitive generic products;
our ability to market, commercialize and achieve market acceptance for our product candidates; our ability to produce sufficient amounts of drug product candidates for commercialization; our ability to raise capital when needed and on acceptable
terms; regulatory developments in the United States, the European Union and other jurisdictions; our ability to protect our intellectual property and <FONT STYLE="white-space:nowrap">know-how</FONT> and operate our business without infringing the
intellectual property rights or regulatory exclusivity of others; our ability to manage negative consequences from changes in applicable laws and regulations, including tax laws (including the Biosecure Act), our ability to maintain an effective
system of internal control over financial reporting; changes and uncertainty in general market conditions; disruptions at the FDA and other agencies; changes and uncertainty in general market, political and economic conditions, including as a result
of inflation and geopolitical conflicts; changes in regulations and customs, tariffs and trade barriers; and the other factors described under the headings &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; and &#8220;Item 3.
Key Information&#8212;D. Risk Factors&#8221; in our Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> and other periodic filings with the U.S. Securities and Exchange Commission. These and other important factors could cause actual
results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management&#8217;s estimates as of the date of this press release. New risks and
uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. While Pharvaris may elect to update such forward-looking statements at some point in the future, Pharvaris disclaims any obligation to do so,
even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing Pharvaris&#8217; views as of any date subsequent to the date of this press release. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g69798g1203082500149.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maggie Beller </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Director, Head of Corporate and Investor
Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">maggie.beller@pharvaris.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g69798g1203081828490.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g69798g1203081828490.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@!=P*H P$1  (1 0,1 ?_$ /<
M 0 !! ,! 0$            (!08'"0(#! $*"P$!  $% 0$!
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M\9<5:9;Z1( VACFMR]E_,';?XL4;&C93L''%=;\//#?7KGQXM?PXZM$'^&O
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M8'_!>MZUJ5\/#'>Q&CQ'%0]+F [<-A(Q7\K3WY/_ .D-B_R_,?AN?<WLUO\
M09U!<-]Y7WK7>;Y$]^3_ /I#8O\ +\Q^&X]FM_H,Z@GO._\ 6N\WR)[\G_\
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M(0AS^\3?1*8WR?QH"/\ 2/T,'1'@5[P=7YU!X4E )[YN'Z)^58B62%%91(3
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M78=Q!W8$'>:8%MVG+?3F>IEGGNZ3D-QLI]Q5H6$=ED'Q'U?VE9=1+0[E=/\
M[N<O9"UU=86IVRRS=9LLD<%/I" 9:WU.VN'3@9FLMRW,7"@HZ-LM>6@:X5J
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MP- 05E1J]C4',<:\WHAU.7;FH#S;#57[.=Z&KY.K'=TFPU>EWJBS%YF:Y*[
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MV31,?&QH#I#)*UM3+7,UH;\UH[1VFBWK@YMA.^2WGA#YBQQJ2<*,>[T:4.(
MQ.%*@+195'-::VZN/+M&2DW2VEKB75PA(-\E%3,S5&LV@M88:'E%B*(1<G)P
MR:S=NX,4Q4%5"G$!Z>,Z;,V=UJ]MLX-N3&<CG"H#J=DD;P#0D;UJ9,$5_65M
M8 _$###\R_3MW76SM=WY\-&L=P%S['M3=J]9OG?'JC7_ ,/"C:AHK"![A]@=
ML-52K4;W )V*:KX)2>V&;\Q)%!K++@<5Y=PW*D85#)*J\3T.'6]+XP?I=OJ4
M][+%ITC[Y\KRZ".X<28<H=41G82T;& D[P.EW@TVZTL3RVS(@Z:D8 HXM =B
M3@74.45?B)*UP4DOCW=N^BM7]EM@FX3MT[>Z"_JO=UK.@=K<[VXZV/6+KJW1
MDAHN"L=GUMWCOV+9%6!V3,V!RZ69Q\^8\FX6(DJE_P#&$V)\+=7U6]XC;'+=
MW4K'V,C[@3R9F23"8M;):@GM1AHH7,[(&!W*>++.RBTESV0QM(>,A8VCFC*<
M)=]:D&CJNP<=@*PAV(=J&@^\/X,?;3HK<VW970TEMSXM=GUWKJ\U+4S79-EL
MFQ)S4<LUJ=*DUSR4+]7ZJL=19TZ>.'!T2>G*D4@'4*HGDN)]=U3A[Q#O-3TZ
M 7+(-#:^1CI3&UL8F!<\8.S.V  "N-:X4-C2]-M=2X>@M;AV3/<@ Y:DDP"@
MJ"TC;7;NV*)^@_@D4.P-W+?NC[N5M'3^P^^K8OP].V9C2-1O-DL]F[IUS)2<
M&^MUN=+S\)]3]>2<_'>B0$/,<D5$154('2!\]JOB7=0N!T6P]IBBTV.^N"^4
M1F.*0!P:WLNS/#3F.P<E5B[/A"W<UWMD^5SIC%'1I-7!P;4T<*#,0,:G?045
M'UI\$@]@==HE;V)NV7J-X[A._P![ANQJ_P 5!TV-FHK7SO0;.WJKW>MOWLTQ
M<60;$XJ@=#5RDU*DBY >L3%X&Y>>)1B;?S6ELU]M:Z7!>,)>07B;+1KAE.6@
M=M!-:*8.#HG=TV27MNG<QV%:4+1N<-F;=0X>16=L3X5O;]JKLP7[F+]WB2=8
MV-;>XWN![8=':CD]6B:%V-?].;@=:YCI*<OK"7>MJ-65:]%N9F:=/$ 29!T)
M(J*#R)O19\=ZK?<0C1[73VOM&6D-Q-*),8V2Q=X0&%H+W9B&M#3CB2 K4_"U
MG!I[KM\Q[SO'-:,I%:.:*US4  )V@[MI5(^*%\+#4WP[ZO MHWN4OEXV^C9X
M:N3M$V'V_P!CUI5-EP,M565A6V]VU[/9O[+2MBZVA9)V,8\2</D)5)=,QA2
M"](WN"N.+_BR=Q?9Q1Z>6%S7QSMD=&X.+>ZN(R&OCD(&84!:1OWKRZ]P]9Z3
M ,DKC<-I4&-P:X$5S,=5S2VO9^::[J+2OG2%IR81,(F$7]7S_A^__1W['?\
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M.X]_[G<?T/LI]VM#_P"G;UN^TOH? E^$4 @/_D2TSX#SXEM@A_# ;,("&/\
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MX4X<N'W>@:=9V5S(S(YT,3(W.;6N4EH%145H=ZRCF76RIA$PB^" & 0$ $!
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MBGOE.%1+\ID?-)\QASJ>D\3:)K;1[ON&.E^@>R\=+30]51SKZ,X9\0.$>+F
MZ)>Q/N",8G')*.8QNHX]+:CG6:<SRW),(F$3"+&6Y:[LRUZOND!IO8C/5&TI
M"%<$HVP)*JQMWB:Y84Q(LP<S%4E3)M9N(743\ETB"B2WDJ&,D<B@%$/;ILUE
M;WT4NHPFXL0X9XPXL+F[P'C%IW@T(KM%%Y[ID\EN]EJ\1W!'9<0' '=4':.5
M?@"[N_CJ_'A['=ZVWM\[A)+3M7O%5<>:U=)Z/KZ];N=<<*JEB+E3)@RJ*<W6
M)M)(3)+$Z5$C@=%8B:Z:B9?JO0?#'PNXETR/5M);<26L@]<[,QV]CQ\U[=XW
MX$5!!7(]3XKXJTJZ=:7>1L@/T6T(W$&F(.X^3 @@?EZVEL>S[BV7L#;5V69N
M;ELRXV&]6IQ',DHU@O8+1)N)>6591Z BBR:J/71Q(D7Z)"CP'LSM5E:0Z?9Q
M6-L"+>&-K&U-3E: T5.\T&U:!<3R74[KB7^L>XN/2XDGSE6)GI5A9$U%M&VZ
M0VIKC<M"78M;QJJ[UG8-0<R;!&5C4+)49=I.0RS^,<?>)!HF_9)BHB?Z*A0$
MH^ YY+^R@U*QFT^Z!-M/$Z-X!H<KP6FA&PT.W<K]M<26EPRYBIWL;PX;\6D$
M><+]0G9W\<SX\??5O>I]O?;W*:<L=RLJY5Y.27T=7T*O1:PBLD27NMUER**D
MAZW#)J@)SB!EG"HD00(HNH0AN+<0>&?A=PQI<FK:LVX9;,& []V9[MS&#YSG
M<FP"I) !*Z#I?%/%6KW3;6U+"XG$Y&T WDFF &\_"2 ?W^ZD@-AU?6M-@-LW
M]MM+94;"-4;M?F57C:7'V6PFZE9!]&56),HR@XLJR@IMD .JH5 A?,444$QQ
M^5-0ELY[V26PB,%DYQR1EQ>6MW O.+CRG#'8 %UNV9-' UER_O)P.TZ@;4\P
M&P+(N>-7TPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PBBCN#]\YV?_LS?'[FB69"W_D;C_+_ 'E0?2'E4KLQZK3")A%Q.8I"
MF.<P%(0HF,8P\ 4I0$3&$?D  # !)H-J@D 5. "_.)<I5WM/=\\Y1$'#FY["
M5;,@ Q3E%*1F"Q\8F!AX(*1&HHD^8 #/MG1)(^'>%((W^A:60<[I:PO=_2JO
MRCXLAFXW\1KN:/%^HZJ6-I]%\HB93F# %MS[Y++9-,=A'=+:]:SSNH6O6/;'
MM.9I-EC?*1>UV:JFO9=S!2[+K1713<QSMDFJ3DAR@8OL'/DG0@S5^*[7V]O>
M,N;YG>-/S@^09@>FI"_4N"TBTK2&6-IV8;>W#&4PH&,#6X= "TZZ$[NNYW1^
MB>WM*'JG=1N+N3[RK#"P=)AOB%;+UQ7M?,&M%T8ZV_L+8=!E]*QUMEF5%L+8
M_I8]H_11D5G1DSJ)IIHJ=>\:EH>CZEJ5V9'V5OI&GL+GFQCD=(<\XB9&\3%H
M+VG%Q:<H%:$DA6XYYHXV4#W32;,Y%,!4D4K@H6["^(3WA=T.]9N]]HUJ[R8F
MZV_MB[+MP]M?;OJBG0.PM#0]\V#/3[';T-W+3$K5G$+#49RT@W!$)-T^B1<$
M1.NAT*E\D,_:\+Z#HVG-M==98.MV7MW%<3R.<R8LC:TQ&W <"7U<#E#74) .
M&*LNN9YI"Z R9BQA: *BI..;#9U+]C; ST[%D:23;I2)FC8T@DT.=1JD]%$@
MNDVRB@ H=N1<3 03 !A* "/CG!W9<QR5RUPKMHLX*TQVKUY2B81,(F$3"*W;
M-4:M=(Q:&MM>A['%KE$JC&9CVS]#Q_CR%<)G%)0/D.02F*/B AGFN[*TOX3!
M>Q,EA.YS0X>=8_4M)TS6;8V>K6\-S:NVMD8'CR5!H><8J .UOAOZTM NI+6L
MR_H$JJ/F$C'0JS=9.?QY(1)90)1B4PFYY*LJ4!#[CCPSF^L>%VE759=)D=;3
M'YI[<?4>TWR$]"X-Q1^';AO4<USPS-)I]T=D9K) 3R4)SL_9<0/HK6QLWM.W
MSIIP>2D*P^DHIDJ)T;73E%Y5@B!# 8CA4[5-.1C $0 >5TD@ 0\1\,Y9JW!W
M$6B.,L\+GP-_M(JN Y\.TWR@=*^=.)?"WCGA%YN+NT?):,-1/;DR-'.<M)&=
M):*<JNW5G?-O;6)D(]_,DO<$V%-(T1<16>.T$4R@3RFDT4Y)5 2D#Z(*'6(
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MPB81,(F$3"*S[EK^D;#C3Q%WJT)9X\Y3$!"78(.C(@;VF:N#%!RS4^8Z1R&
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M'8_HO: .GS>"&B6)QUG":J!4F*)ES"(^:[A#%&)<\F'DW2FD<WRFS2=9\/\
MA[5JRMC]FNC\^+LX\[/1/4#SKDG%7@IP1Q,77$4!L-1=_:6]& GE=%_5NY\
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MSQR\=$\-2:!::?9VUW<6\4$]S&"UTT,+@Y@,8I&V1Q [R45<^@K0J@W+C!W
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MP7!2!S95OR81,(F$3"*DSW^!);_%[O\ K)\\]W_*R?J.^ KQ:E_M\_\ A/\
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MQTBR7(L@LD<R:J9P,41 0S4Y8I89'0S-<R9A+7-<"'-<#0@@X@@X$'$%6'8
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MO\"2W^+W?]9/GGN_Y63]1WP%>+4O]OG_ ,)_[I45%/Z(K_55/Y\V:4N4#8L
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M.YGMLU!>JS8K;K;=='UE?M9[5NM9"&6?NU;+$S>F-\:@NRA :7F,E$EWSN/
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MD#J!A(ZT1RSE8O@D1XD(_=AF'AT;5;B1\5O;RODCE;$X-:321Q(:PT^<2UP
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M3L[: UY"< [T2< :IE=3-3LJI,;]2Y.\36M8ZR1CZ_5R(9ST_5&IU5I:'AY
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MI1NUI<8,G%Q&Q.X]QVJMZD];+6=%,EXJ^WV:[67:E4,U;M43+HN5P$I385W
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M M(:<PJ#LQ'GN'AK2UX<6$;0*_EY<%'_ +?:FUG-S02EWV[O;8Q4MIVK=T#
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MW/7U?NM\G-;,K,VCT76NZ/<+,_LT1JV*<1Y$P?UFC*R:S6-56*#@&?0F<3=
M".%U_67Z_J'O.:-D=TZ-@D+2:2/8T-,AKL<^@+@,*U.]7;>$6\?=-)+ 32NX
M'&GD4JLPJOIA$PBAQW9]\>G>SESJR)V/#[/N%LW-+6J-U_1=0:_E=CW6;;T.
M +:;S+MJ_$G3=.&-6KQP<K)(><^< ()M6[A4>C,]HG#M_KPF?:.AC@MPTO?*
M\1L&=V5@+C@"YV )HT;7$#%6)[B."@?4N=6@ J<-JP19?BZ=H-3L5SJ,LZVB
M2TZ_D]WLK97B:WEDYJ&CNW_4%;WE>[.^C':[5XRK2VOK='+QRZY$E'CER#?R
MR*E.4N2BX'UV:*.9G<]U*V$M/>"A,\KH6-!&!=G:X. V 5K16S>P-):<U16N
M'(,Q\E"K3U/\9[M&V[LVEZIBZUW&U&PWFWQE%C)'8VB;93:U'6:T:[5VIKR,
MGYR0$S:)<[0H[99[ IG 5'::0B<J(&3$]^]X URQLY+Y[K5\4<9D(9,USBUL
MG=2%H&T1OHU_(3A7%4LOX'N# '@DTQ:1B14=8V+!.ROCX]NT;I2];.T[J#?F
MP;+58O6MLKU*N&MY_6J.Q-=WK<+334KL"ES[QI,H3%;JML,K'K+)(F!654:M
MB\$<@N3)6GAGJKM1CLM0GMHH7ND8Y[7MD[N1D1E#'M!%'.;1P%?1S':*&V_4
MHA&7QM<2*$ BE032HZ"I3RWQ;>TN!VM;]1S?VLQ4M2&=P9S=K>ZPG$-=#LK7
M^IE=VW;13"[*'"(?;IK>ND%7;B&(;CS4%6Y5C+IF(&%9P1K<EC'?Q]P8Y"TA
MHD'>=V^3N63%FT0NDP#^<&E,5>-["'F,YJBN-,*@5(KRTW*PM6_&M[/ML7V@
MZ]B:UW(UB4V)>-2T&(E[]H:V5*KQLOOZJGMVB7EBGWYC,X>)W%&H+%KZIQ$[
MX[=0_05  6'TWGA_KEE;2W4C[1[(8Y'D,F:YQ$+LDP:!B3$2,XW5&-<%2R_@
M>X- >"2!BTCTA4=>Y2CW#WZ:,T=W"UCMJNS39*EZL6J;'O*1G*]0)>?U]0]2
MU \PE9[WL:Y,1,PJ$##+0QDU%'!>5%5T$T@.HJ!<P]APUJ6HZ6_5[<Q>S,G;
M" YX:]\KZ961L.+W&M<-@!)H KS[B..40NKF+:[, !M).Y0*LGQA:3MMAH9?
MM93L,5)6?N][8-5;,KN[-:S-4L2^CNXVO72S4O9%2BGCY%12O[!B*N9Q#20F
M$XD15*H@0_ 9LT/ EQ9.NAK)8YC+"XEC=#('-[Z!S&NC>0-K"ZCV\XH:+S.O
MFO#>YK4R-!J*8.K0^7<KBU-\9OMV1U_VW!N>URT]>]SU"N7"TW76&GKQ$:FU
MS 7[<$[IG7-EV&%DDI27UU"7"[17NQH#M9VNHN05CE3;G(?+-[P#JAN;LZ>Q
MK+:W>YK622L,LCF1-ED;'E $A8PYC0  88N",OXLC.\-7.%20#05-!7DJ5F+
MX;/=YN3O#F^\ZT;'KCZCTO5?=)==':EI,EK21J,G"US6ZRT-).K!<7]DE4[K
M;9:1("TDV09L4813H1 RX*@*?@XLT.PT*/3X;1PDN)K)DTKQ(' ND[0RM#1D
M:!@TDN+]N%%<M)Y)S(YXHUKR *<G/O/P+:)FG+V)A$PB81,(F$6*]DZ2U;MM
MF=K?:;$3:HI&21E#( UFVA1XX%K,-?)?I 00 0+UB3D/$HAF'U70-'UIF34H
M&2&F#J4>.APHX=:U;B/@OA?BR'NM>LX9W4H'TRR-_5D;1XZZ<RUK;9^&<Z2!
MU)Z;MA710 RB56MQBHN X#^@L[ V(""HF'V X13X'VJ#G+-9\*I&UET*?,/5
MR[>@/'_,/*OG3BK\.$\>:YX.NP]NT07&!Z&S-%#S9VCG<H#2M8WMVXV--T\9
MW'7,RB<2MY5DHZ:LG@$,//IY)F<\9)MS#R/3U*%$/NBYSB:TU_A>Z#I&SVEP
M#@X$AIZ'#LN'-BN$7>F\:^'FHB6=EYIEZ#A(TEK'=#VDQO',2>A3$U+\2:]U
M\&\9M>!:W>/)PF:;B00A;$F3Z)2G60*3W3("4/$0Z6YC#XB?Y,WC1O%+4K:D
M6L1MN(?IMHQXZ1Z+OZ)YUUWA7\16OZ?EM^*8&7UL,.]CI',!RD?U;_Z!/*MF
M.K.Z'2NWR(HU6Y,D)E4I1-6YX2PLX0YN \I)J\,5)\<!'_\ +*+9U71^+M!U
ML!MG.T3G^S?V']1V_LDKZ0X7\3>#.+@&:7>,;>D?U,O\.4'D#7>E^P7*0.;*
MM^3")A$PBQM<Z624(>1CB%(^(43*)@' +@'B/ !_'?\ V^/S@.%U'3A(#/ /
MXF\<O1S_  K5=<T/OZWEF/X^US1\[G'Z7P]*P.HFHBH=)4AB*$,)3D,' E$/
MD'-<V8%:-LP.U<,*%V(HJN%2(HD%150W20A?:(C_ ,P!\H_)D@$F@Q)4@$D-
M;BX[ L_4VFIPR97SXI5)!0H"4H@ @W ?$..0\#A_$'Q]O'&RZ=IPA GG'\;<
M/H_G^!;YH>ABU N[L W)V#Z'_P!7P+(69=;.F$3")A$PB81,(F$3")A$PB81
M6[;/\WY/]C*_SAL\6H_R;^CXUB=<_P!JF_5^,*+@>P/X ?\ -FGKF*^X1,(F
M$7T#&*/)1$H\"'("(#P(<"'(?((#A%](<Z8]29C$-P)>2B)1X$.!#D/D$,;=
MJ+Z=5103"=0YQ.(&,)C&-U&*'24QN1'D2E\ ^8,@ #8B^^<KY?E>:IY? !Y?
M6;HX W4 =//' &\>/G\<4%:[T7 !$O/ B'("4>!$.2CX" \?((>W)1=A5UB<
M]*JA>0 !X.8.0* E* \#["E'@/F#(+0=H1<04.''!SAP! #@P^ )CRF >/L(
M(>'S9- B'445$!4.8XAX )S"80 1$1XY^<1Y_@X  V(N&$3")A$PB8129I?^
M;S+_ *I?ZTEFV:5_)MZ2ND\/?[7'TGX5=>9%9M1][EIB-I&IK]L^46V.NVI-
M MP'A-<VUQ5)*3),$C$_5)OP=LV$9*1:S$AF\NN<A8=!5ROU 05,R>DL?<7L
M=HP15DE;B]N8"E<*4)(-<6CTC0<BMRD-87FN W?EY]RBWV_4G=3#9M4G;(2=
M^J9FK]RJ=_WWW[=21D'D0L+ RM#DJ)$P%D$QU2""OK"IHC]^3$_2 #F-3N-/
M=:/CAR]]4;+-D6PX]L/+F]6.PJS$V0/!/H_KD^:BSQN#]\YV?_LS?'[FB682
MW_D;C_+_ 'E?/I#RJ5V8]5IA$PB_/)\:4P%V5I,0'Z0TBQ (=7\:$ZD(#T\^
M'(B/C\N<I\0Y,EY;#^Z=^\%]'>"$(ETJ_)&RX9^X5.3X21@-VAL! >1^T:]
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MQ@XYX6(@CN3=V+#0PW-7TIN#ZB1G14@<BV7ZH^(AJ"["WC[R@]UK,J"1,5Y
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M)"^]TR]!J6.#FM=TL=6.0>0CG4\]3_$QDFXM8S<523D$N2IJVBH@FU>%*)@
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M[WZWYE@B;;),Y:1:H ((MWKE%,!XY B2ZA"A]$"AX%+\@!FN3L$<[XV^BUQ
M6C7D38+N6%GH,>0.@%4O+2\RJD(U2>RC-JN BDJKP<"B "( 4QN/$#!QR'S9
M<A:'RM8[87 *] QLD[(W>BYX!Z"5G?[/*Y_25O[F_!<V3W/9_I]?YEOGW7TS
M^]^M^9/L\KG])6_N;\%Q[GL_T^O\R?=?3/[WZWYD^SRN?TE;^YOP7'N>S_3Z
M_P R?=?3/[WZWYD^SRN?TE;^YOP7'N>S_3Z_S)]U],_O?K?F3[/*Y_25O[F_
M!<>Y[/\ 3Z_S)]U],_O?K?F3[/*Y_25O[F_!<>Y[/]/K_,GW7TS^]^M^9/L\
MKG])6_N;\%Q[GL_T^O\ ,GW7TS^]^M^977'1[>,:D:-NOR4_N0.)1$/ "@ =
M!2%   H>P S(00LMXQ%'7*%F;2UBLH!;PU[L<NU>[+J]*Q#OP-H#IC9/V+JE
M1VD%5DC4Q3_NGU!94I"F$(T9\IH LT9H"H,!?@+$'HI"X^\]>>[3?8_;XO;_
M .3SC-MV<^7M4KMIC2M,51)GR'N_3I@M=.HHGN'B.XO7+5&Y]UE[J$A:9FX/
MGVRKIK&1U ZT+8]9%5C0G#UA@SFC;7I&SE2,#1S,AFIE%#*&56:^2<FTWK]+
MDTJ5QCLHYPP, 8R02B9LF.7,2.[?'CF..Z@-5Y6=Z)0*O+:UQ(I2G-O!4QMP
M?OG.S_\ 9F^/W-$LUBW_ )&X_P O]Y>H^D/*I79CU6F$3"+\XOQU#^7<NWPW
M3QU5RZ!U\AX\242/1\_T>>?X>?,/X@9C#J&F4WPR_O,7W_\ @OMO:-%UZNZY
MMO.R136^#$?K[-2C[?\ ]U[^'MY_CHC@/X09OG@;*9>",Q_ZR;_E7'_Q<0B#
MQ:R#_M=J?,];9,[$OF!,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%0+5::[2*Y-6^VR
M[* K-=CG,M-S,@IY3*-CFA!4<.G"@ 8033('R (B/@ "(\9YKR\MM/M9+V]>
MV.TB:7/<[ -:-I*\.IZG8:-I\VJZK*R#3K>,ODD>:-8QHJ7$\@569/&LBS:2
M#%PD[9/FR#QFZ0."B+EJY2*NW<(G+X'261.!BB'@(#E]CV2L$D9!C< 01L(.
M((Z0O5%+'/$V>%P="]H<TC$$$5!!Y",0K,O>K]?;-CQC+Y482S->D2I&D629
MWC41#[ME()^6_9*![0,DH00$,\&H:3IFJQ]UJ,$<S/TAB.@[1Y"%AM<X9T#B
M6W]FUVT@N8J89V@N;^J[TFGG:0M<^UOAGP+_ -3)Z@M:T(X$ACIUJU"H^C#G
M HB";6:;)B^:%,( 4 52<<>T39S#6/"J!]9=$G,;O5R=IOD>.T/*'+YZXH_#
M?9S9KGA"[=#)M$,]7L/,V0=MO[0?TK79==*[XT!+)R<Q 62LJ,U>IG:Z\X<*
MQG40W!3HSL2H9)'GGP*H8AO'V<^&<RO]"XAX;G$UQ%+"YIPE826_7;LZ#1?/
MNM<'<;\"78NK^VN;5[#V;B$DLPWB6,T'0ZAYE(35/Q$-PTH&T=>$6>R89+A,
MZTF;W=9$TP$?$LPU1,FZ4+\[A%4X@'B;GQS9='\2]<L*1W^6[M^5W9D^N!0_
MM ]*Z!POX_\ %^BY8-9#-3LAO?V)@.:1HH[]MI/.MEVJN]71.TO3,B60*=8%
MP*7W'<!1BQ.L;I 2,Y45#1+L.HP 7[Z101'CH ?#.JZ-QYP]J^6/O>XNC\R7
MLX\SO1/77F7T=PMXS<#\3Y8!<>QZB[^RN*,->1KZ]V[FHX$\BEDFHFLF15)0
MBJ2A2G343,4Z:A#!R4Y#E$2F*8!Y 0'@0S<@0148@KJK7-<T.:06D8$;"N>2
MI3")A$PB81,(F$3")A$PB81,(F$3"+I<"X!!46I4C. *(I%6$P)&.'CTG,3Z
M10,'AS\@Y2_/E/=TSTPKL5N7O!&3" 9:85V5YZ+%;_8DC&.E&CR*3263,("
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M^,[UT31]'CTZ/O)*.O'#$_1'T6_&=_0KOS(K.)A$PB81,(F$3")A%@7N:<7
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ME>E0I/=<WDFHZ3++"V0L:1F#KJ21S144<8G  M)(&;&AVTP5#6".4 TJ=G9
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ME<:99V5C;C38H].=.ZWTWOXWNA,;B)9^_<ZK\CI&LQ)!+AM&-%$KWO=WA,@
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ME@(<GIGU2T%O);Z;:MM^] :]Q>Z1Q:"#E!- T$@$T;4TI6BI$3LP=(XNIL%
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M#YPJ ?VAV7#RE<.N;'C7P]U'O)67NF7H.#VES6NZ'MK'(#R5/0IBZI^)/?8
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M\B^S7>EL^O.5*'.T&DQVT9JR5<E76CG.Q;I2F%2M>L[#M$J]B:4ZG2MT>SL
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MLC(]G0K[VN.W9BS*L!'1<C&6=FZ6=N7R+:.0%47AT!;K@2T=*F]J9:M?&[O
M2' DM.6H<!AF)!:0  2XTRUJ%5WHREQ!%%T!W)P"B<XZ;T38Z\;7(1J^F98(
MB&1BHZP.H"$M 4R0D',^@UCII&"L31P=TN=.' J@@#P3!P-7NJ4%K3)$'/<0
M!4U+0XMS !M2*M(H.U^BH[T8X&@6(T.^C7[8TK+3+5<M8=*P2E1]V&CEI]>,
M"J)3]ZD9-!Q,)QT@%1>'%$$HI5XN^Y)Z1-R)RB/M/#MT:,C/\45S5K2N:C ,
M*C,,:NH!\ZBH]H;M/H[OCZE*+6%Q>W*"E599-BG.5JWVRE3GNT5/0*R-7FG4
M:#QH58ZBR*4@R(BX\LXB9,51*/LS#WD#8) &5[M[&O%=M'"M/(:A76.S#':"
M1U+(^>55IA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB816M=*76=A5F5I]OBD)B F6XMWK)?D.>! Z2Z"I!*JV=-E2@=)0@@<A
MP 0'/'?V%IJ=H^QOF"2VD%"#\(Y"-H(Q!6+UG1M-X@TV72-7B;-83-HYI\Q!
MVAP.+7"A!Q"U\&^&-JX9[UI;Y<BU_P!0"ON+R(H7/D>/+4)GR@, ?]/R!-QG
M-?\ Q/I/M&<7-Q[+7T*-K3DSTKY:57 S^&KAKV[O1?WHT[-7NJ,S4Y.]I7RY
M:K8'1J-5M;U>*IM-BD(:OPR'DLV:/4<QC&,)UW3I=03+.GCI4PG55.(G.8?$
M?8&=)T_3[/2K1EC8L$=M&* #SDG:2=I)Q*[WHFB:9P[ID6CZ/$V&PA;1K1UD
MDG%SG'%SCB2KMSVK*IA$PB81,(F$3")A$PB81,(F$45]_P!'W!+[!T5L74$-
M1[#(ZRD-AFF(F\V:5JS%PSN-42@6ZK1]$P%B<'<-UBB82"B!>/ESWVDMLV&6
M&Y+PUX;0M )[)KO(5+@:@C<O']:.]K\4';Q^6:\?FIR<FE^LG^HW[:BK^0=:
MZU;'WK+IG16TYVZJI*%$BB9]R7<Q#E'V@8HZIX$,AT6E.!:Y\Q:?T&_;53'R
ML<'LP<#@:JQW41WBJJF.UU'V]-4S>((CN2^K@4?E AS:R3,!?F >>,QDFCZ.
MYQ+)KAK>3NVG_G6=AX@NV,#9HV/=RU(/E "\H0W>@(^.JNWD ^?[7[V/_P#S
M;Y<M^YM*_P"HG_\ XV_;5[[Q2C9"SZQ^RJ_#I]XL0H#@FF^WAP\*(]#E7<U[
MX3 0X^](FU:H1,W_ $N1-^CGKM].T:W.;O)W2<I8WS#.L=>ZM>7@[NC60_1!
M./2:5/1L5S_6CO:_%!V\?EFO'YJ<]N32_63_ %&_;6+J_D'6NI:U][Y$S&1T
MWV[K*!QTICNJ[I /_OCJ<P!Q_ R6QZ430RS <N1I_P"=4O=*UM6,#G<E:><B
MBZ6UN[Y51-ZG2G;LU  ^B(;ONKCJ'YN"ZE)TY4Z+26^C-,[_ "P/A>K<4MP_
M^LBR?M _ O7]:.]K\4';Q^6:\?FIRC)I?K)_J-^VKU7\@ZT^M'>U^*#MX_+-
M>/S4XR:7ZR?ZC?MI5_(.M/K1WM?B@[>/RS7C\U.,FE^LG^HW[:5?R#K3ZT=[
M7XH.WC\LUX_-3C)I?K)_J-^VE7\@ZT^M'>U^*#MX_+->/S4XR:7ZR?ZC?MI5
M_(.M/K1WM?B@[>/RS7C\U.,FE^LG^HW[:5?R#K3ZT=[7XH.WC\LUX_-3C)I?
MK)_J-^VE7\@ZT^M'>U^*#MX_+->/S4XR:7ZR?ZC?MI5_(.M/K1WM?B@[>/RS
M7C\U.,FE^LG^HW[:5?R#K3ZT=[7XH.WC\LUX_-3C)I?K)_J-^VE7\@ZT^M'>
MU^*#MX_+->/S4XR:7ZR?ZC?MI5_(.M/K1WM?B@[>/RS7C\U.,FE^LG^HW[:5
M?R#K3ZT=[7XH.WC\LUX_-3C)I?K)_J-^VE7\@ZT^M'>U^*#MX_+->/S4XR:7
MZR?ZC?MI5_(.M/K1WM?B@[>/RS7C\U.,FE^LG^HW[:5?R#K3ZT=[7XH.WC\L
MUX_-3C)I?K)_J-^VE7\@ZT^M'>U^*#MX_+->/S4XR:7ZR?ZC?MI5_(.M/K1W
MM?B@[>/RS7C\U.,FE^LG^HW[:5?R#K3ZT=[7XH.WC\LUX_-3C)I?K)_J-^VE
M7\@ZT^M'>U^*#MX_+->/S4XR:7ZR?ZC?MI5_(.M/K1WM?B@[>/RS7C\U.,FE
M^LG^HW[:5?R#K3ZT=[7XH.WC\LUX_-3C)I?K)_J-^VE7\@ZT^M'>U^*#MX_+
M->/S4XR:7ZR?ZC?MI5_(.M6K8V?=M;']0E)[2';T]?4.R_6^JK%WCL%L$;8?
M<,Y61>G3;ZN33>$]RV1XEY2H'3Y5 _'44HA>BDL86R,CEF#9&97?PVXMS!U/
M3PQ:#@H(<2"0,#7:L=+:;WRXE+3,J]N_;^:1ND+LFO61?_S!;0 K^(VXXA76
MP&I$@UH";09I>O-!*=("G;>4()"0#&Y]0U&$,9&)YLL;HW-_ALP,=<GSMV8]
M.]4=UB305-=YW[5X[!H_?UBEOK$MHW3L)9TW-4=LK54^YG;-:LD4XI5?FJI
MFB91AK0#LD@K=A>LG:729)^@N(+E/P42U1:G#$SNA+(Z&C@6NAC<TYR'&H+L
M>TT$'<1@ABJ:TQPWG<KEM-,[O+/ TZO+:KT09K37B?IG,QO/9$])RD.ZK\K4
M;#&2\N[UL26>.Y^M3;E([TRQEB.3$7$#B3I&U#=:?#+)+GEK(,:1L !J'-(
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MCXB/&2 2:#:B[\A%U++(MDE%W"J2""11.JLLH1))(A?$QU%#B4A"@'M$1 ,
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ML&@DTKLW)4*X@$! ! >0'Q 0\0$!^4,H1,(N)SD3(=10Y4TTRF.HH<P$(0A
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M_)5(IT@J0%$Q-T&-T@HF8#%Y]H#R'ABA&U%W81,(N!U")$,HJ<B:9"B8ZAS
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M\2G&JQU87VVZP6S/YNQ3;:J18PB/K6C>M$EEH86S41DXV4D54(H)\985$WR
MMP*HBI]ZX$I -=8+=V4 #.:\M*]')38HQ\B\$DTW5-Q$6DC]<&R,I#-9=^K
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M519==F]G&T:J,W%)$?LZR9Y]9'3CK 1B3HHL3&:HJ]1GAN"\I\&$ MB6AV;
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M4PF.824OA;%V7FKR-V[IY>92#59HZ0YZN YXZ>> YX]O'/MXY'/,I0"E#Q
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MK)PQZ<V:-G"#.47)*TU>,9NY-V[DUEV$PF[A2EC9QNI7U%P3= "JP)=9.0*
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MSF*DY*J4Q0X-SE;8+G-EK3$';LKA7R;^114+I->=#APUD:[&1Q7$*P92 R-
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MLU;N6CQ!LK&,CMT7<>0J;!TDB9 4TW#),@%2.  9,H !1 ,![P:@FJ+O]RQ
M ;RXUBB8R8I@J@T016(46ZK7[VJFF51,Q6RYR (" @4P@'@(XS.Y2BH\?1J?
M%P85MI6H0D)Z,&"T>>+9*-WC?[V*A7R9T!(],NHD4ZAE ,*B@=1N1\<DR2.=
MF).910*L*0L.J+ 58J-4&+3%&,%1BV.,<B8$0,DQ$R0^E3,#9/DJ?2 ^67^1
M#B,SL<3CMYU*IZE.J2RAUE:O7E55)7WXHJI"QQU#S724OO<QS-A,:3Z2@'GC
M]]\/NLGO'C8X[*;=W(E O6E78!$GE(P<.DGUK*>6G&LB$\QP"X.#])40+U+@
MY4 X^TP*&Y^Z'F"]YVDHN+6MUYB"Y64%#-"NG*SQR5M&,D"KNW"R#EPY6!-$
MH*+KN&J2ASCR8QTRF$>2@("]YVDGRHOBE:KBK(8Q2 AE(X6:T<+ \8R,S] X
M6(X78^F,@*/I%G"93F3XZ!.4#"'( .,[ZYJFO2BXO:O6I*/]TR%>A'T5YZ3G
MW:[BF+AB#E$H$1< U50,@5PB0H 0X%ZB@' "& ]X.8$YNE*+XO5:PZ.NJYKL
M&X5=1I89RHO%,55'$002F)%K'40,96/(8A1!$PBF E#P\ R1(\;"=M=N_E2@
M7UU5JR]:@Q>5V#=L@Z>&CF)8+M@Z#(&)P@H@9(.DS5(0\/\ X9?Y$.(#W@U!
M->E*!=9JC5#'\PU9@#*>]23G6:'CQ/[Z2+T)R_4+?GWF0H\ O_10Y^ZR>\D^
MD=E-N[DZ$H%]:U.JL3^8RK4 T4]4Y?>8VAX] _K7@IB[=]23<IO4NA2)YA_N
MC]!>1'@.!D>=I)\J4"]):_ D=,WQ(2)(]CO6BP>$CFA7+(9)4R\CZ1<J(*M_
M7KG,=;H$/-.(F-R(\Y&=U"*FA1?$Z] (D,FC!PZ29P5 R:<:R(0P+.#.U@,4
MJ(%$%71A5,'RJ#U#X^.,[SO**DRU"ILX"@2=:AG(KJLE79ACFA3OBL'@R#9L
M^.5$#/&97@BH*2@F3,81$0'*FRR-V./6HH%4R5FN$5<+D@(4BSM-HDZ5+%L2
MJ.4F"!VS)-<X(=2I&;8YDT@-R"9!$I> \,ISOY3@I7!Y5JQ('.H_KL$].JHD
MJH=W$L'!E%6[I=Z@HH95N<3G1>.5%2B/(E44,8/$PB(/>W82/*E O6I"PZKA
M1XK$QBKM4PG5=*,&IW"AA201$RBYDA5.846R9.1'[E,H>PH<,S@* FB+J3KL
M DGY24'#II><=QY1(UD1/U"AU%#K]!40+YIU%CF$W'(F.(^T1QG=MJ47J+&1
MI$5FY(]B5NX!(JZ!6C<J*Y44TT42K) F!% 222*4H& >DI0 /  R*G;4U1>)
MK6JXQ7D73*!AFCF8<$>2R[:,9(*R;M-<SHCJ0.DB4SQR5T<5 44ZC^8(FYY\
M<DO>:5)PV8[$72YJ55>^L%Y6H!T,@S)'OQ<0\>L+U@DY%XFR="HW,+AJF['S
M2IFY*"GTN.KQR1(\4HXX<Z4"[_JU7>J.-[AA0-#K&<1)@BV0#&+F*0AEH\00
M_L-4Q4R@)D^D1 H?,&1G?CB<=N.U**EMZ%3FXRQAKD.Y4G9;WW+JO8]H]6?R
M17)G:#ARJY14.J+)<XB@!A$$.?H<9499#3$X"@44"J;6M5UDZ,^90,,T>G>N
M9(SQM&,D'1I!XCZ9V^,X21*J+MTW^]J*<]9R?1$1#PRDO>10DTZ5-%\6K%;<
M-G;->OPBS206%P_:J13$[=ZX%T=\*[M$R IN%A>J&6$QP$WFF$_/4(C@/>#4
M$U'.E NOZI54%G3@*U >>]<-W;Q;W/'^:[=-2J$:N7*GI^M=PW(L<"',(F(!
MS<"'(Y/>/I3,:#G2@7:[K5<?I&0?0$*\1.L5P=)S%LETS."JHKE7,11 Q16!
M9NF;J]O40H^T R ]XV$I1=XPD,95NN,1&"NT7!RU6] U\ULY#U7#A!3RNM%8
M/6K?2*(&^_'\?IFY9G<IQ1>)>HU5S)O)IQ6H%>7D&[9H_E%HA@K(/6K)9%PS
M;NWAVYG#A%JNV3.F4YA ADR"' E+Q(DD#<H<<HW5P2@7O>0T1(,7D8_BXYY'
M2)CG?L'3)NNS>G4.510[MLJF9%P<ZA ,(G 1$P /M#(#G AP)!"+K- 09H]>
M)-#10Q;I%)LYC1CV@L'#=%)-!%!9IY/D*I(H)$(4IBB!2E  \ #&9U<U3F1>
MA*+C$&C1@C',46+ $RL6:31N1JS*B04T0:MRI@BW!),PE+T '2 \!D9G5K4U
M*+Q)5JN(*N5T8"%26>>6#M5.+8D5= BT%@B#@Y4 ,L"3(PHE PCTI")0^B/&
M3G?LJ:#G1=C> @FB;U)K"Q+9*2<^LD4D(YHDF_=]13^J>$(B4KEQUD >LX";
MD.>><%[S2I.&Q%5\I1,(J//M8A[#2+6>412AUVYB2"CAUZ) C<3%$PJ.A42\
M@O(!]+J#*FEP<"WTD5G.(#72DN]<KO8XLLK,Q[IZF,_Y:Q9A$),(],[4'I?)
M7,#ASTI=(=?2/@/1X7 Z;+0 Y:<F[?\ $HP5!A:EJ1&IV2/@Y>+/4)@J:<HH
MQM"*T='"544RF:R2+PWNY4SX1/U"KU>?[/8!<K=)<9VEX/>#94;?(E!3F7K)
M4=9^FG$$YA#HG56*BBI+3]]C5$["Z.P""5*\YB &X^H.F5'I*:0,H0 $0\L*
M>\FJ#39S<V_EP\R4"X%I^L&TRW=N)=%:53?';-T9"VJKJ#/LV+9.3< V7D!,
MI874>5#UQA 55$P*8X!U")G>3%I '9Z-V[R<B4"H1Z#JM25))_6=H2):U^NQ
MRD,C;/+CE4T6C%K69.14+)\NA%@1KZ(5/HG.!%2B<Q@'*Q+.!EIVB3C3'G P
MY=JB@7+ZF:0&',09J#]P'>SCU,H6YJ6+2!W%OF,\T16(^*GZ$K5TJJJF)S>2
M<H' 2^67I=Y<YMASX;L=N"4"K4U3Z(O!U=!>?;HIPWJOJF[D;#_W>]DU4EQ;
M*NT4GK)&<].O]/RR&*)B%,3GH,8HTMDESN(&)VX8_F4T"I</3=/LZ[!1Z<W#
M/6+& 18-'Y;23RGK!.KDC5GI#IRATSIKP0"L)BF,4"#YG/\ '94Z2X+R2#6O
M)S]'*HH%YHO7FKV$?'L'UL"4D"0R:82;FW>6\<Q3[W$VCE&A D#>GC&S]O'J
M1_ECT(N12%,PF/\ 2.EF))#:"O)OQ^*M>9*!5A*I:B2(9$92+441<S*;I5:U
M];E62.:)2L*KXXR(&/(F=,VQG?4 &(L?DP%%3QCO+CD-,-V[&F[J4T"J3NM:
MU<V*-<GDV"%C;24^]:)(6%-&1<N'SIK[_:BW]4+A1!-^1 5$TP*+=;IX$@F$
M!I#Y@PBAR4&[J3#RJUF=#TNT!<2S[-P#>1*66%U=O/(XFG:SDT8>8*,B"9Y5
MH/G%9]0%.7Z? &-R;*^]N#N.SDW;Z<W*HH%WMJ-IQJ[76"<9K.52.GJI'5U.
MXZ(IVV;)>C*DK)&!*!;H B9%, !-/Z @/B'(RW);2AR]&_JVI0+UMJ9JA(KM
M%I-M?4O64:9%P%M!P[91B\FQ<5D([S7RH(QK64;HA'!TF2$X]!>KK$!@R3[Q
M@#R;Z8^6FU30+C:J1JI\\7=VR?22<E+&13TLC;P8(&G$X\$XB4>,3O$&GUJ&
M.X%%4R?F&3X$"B&(Y;@"D8PQ. W5Q'1500-ZK)*WK,CQN<TA'*2"4K%+D,I8
MP]2K,-(NO-H\#I%>E [E:.8L# D!0!0IRGZ1\WDU.>:FPTH=VZI_.IP5L-J+
MIIPVDVL3/LD$G[Y,%CPMS(DNTEV;%YZM1H[:OA=-9)U%%< Z#K$3H>:(E !.
M.5F6X%"1LY1N^2NQ10*I2%*U4]E6+E6:1;2*=:1BXU%K<5&QPB"0KYLTD&R!
M9#S%CD@U5A*L/411(#',!N!-D"2< X89JG#?7Y5- J:_H^DU&]4"1FHL&417
MP8097-U\IM(0QDY$B3DYS29/>*9 7=F(L4W3R)O:"90)+9+D%V4&I..&_JZ%
M% KD>5#73-N+&>EO5+(JQAG;JQVMPO)KN$&E@".,_<O7Y53G49/GW04>"G3(
M;@O2E]&@23$U8.78,-U:4\BF@5(95+32,;!HHRT*O&I+69W63FM:)D$V\K +
M,IMK$JHOTR.HYG ..H"<J@V3*17D#$*<*C)<9B2#7"N'(<*^5*!4>W4'7TZS
MCV4/;8JNO46:QCR"%A.=\>G)R,TXL"#?HF6Y3,5W3UT1914JS<IB=)RCY8 6
MJ.65IJ6DCHWT%-W0H("R)(0-&>L)6/5?M6Q9*V(.W#IK-@UD&ET%5F=D#)X1
MR"S&;(NBCY2!1 P\]/0)3" VFOE!! V-Y-WR*<%2&-7U@$8O#QLE'\/%6[<K
MUE9N9E&2;"FFFX82B+X7S65.Z3 Z@IF*9541ZP, B49+YJYB#U8=7(F"X+57
M6!J\E%+2K((Q&,G(X'XV<".#)KV%BXGWJTAZT 6?DM+=$7"IN>AT/EF .L2"
M[R;/F [51NYL/-YDH%2XJF:=:)-0CYB-612-"I-__P!8>I3.[8MU?=BH"$B8
M%'CEJMXCSRLF4O@(%#*G27!V@[]W+M2@7ACJ/0FUGE)Y"U0ZE94@K1&/*V$Y
MZB.%P\1C1N,G(J+RZ[9)5O'MT2N#)IHF235 53<=/,NEE,89E.>H-:=-!L44
M%>97O4JY18.8>^X)%*0L9&'I98[BPGF9H[0SPSHBLF15VLOU LH4A5#E 0(4
MI.> #+<CY7-&<497#"@\BD45*FJIJ^2=ID?RC)I)BO87*"C>T"QD0 [^4?6Y
M%'I?%5!J<ZSQ)^0H=*:/F$-T 3Z,M?,!@*MPW8;!3XJ)0+P$JFG5)2LKLI6%
M0E6*22U<*RM#<7#B-2>N51;LVYGJPNXQ5XZ$# F40$Q" !@$A>*N\N,K@0<I
MVX<WR)0*N[#@M8S1XO[0W<,V41:2Z,5[UGRP9S-7GN\)8S?E\R,N"9D6_4<.
M11$2B E$WC3"^9M>Y!W5H*]"&F]4[ZK:I%U)N?><9U.47*,BB%G $$^ME9"N
ME3H@_ K=;W=)2'4;PZ4DQ'P!$!*SST H:='1^9*!>^(@=8L5DUXUY#+&2/+J
M%(:>2?(F\^-31F"J(*O5D54B1A %4I@$J:?TA  'G#GSG!P.[=U)@K>K]7T@
M:63EZE)5<JS2>(X<,ZU9F(13FQ/'K\\:62BXU\+)>1;2!W7HDSDZB*=92%'I
MX+6]]SERR!U"-X-:;\3NV544;N7H>5#43A1,ZTM&HG9Q@N'()VP$@<5EO(G5
M>-Y,GO#AS6UY-P4'(*!Y)U")E,/)0#($EQR';R;^;GY%- N,;1M5M6L\T83O
MF&DH9+WDZ^NBSIXSKRB42M&^4LI(*^AAFS)LS*W\ 1%N)2CUD4'J&6>H)&P\
MF_&OEVU44"Z)"D:S43@74A9&A:A"4UC%MHEQ9@3A9&$]Y-1BI.6>GD2^]617
MP(@@=4QDQ<=(@83<!@2S8@-_B%U:TQ!W@<G.E!Y%T/=?:AY02D[%RLB9ZT [
MV]*E=JRCE!J*CQ9121*LI,MF2K<I#>TJ7DB8H]*0ED2W&YO]'\L$H%=CV#UJ
MO/*RCQ]#%E$VS1L\:C--F[<Y6YK*=NL^C$W*:!W!RNY0#'.3E0H+ ;GRQZ:
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8$PB81,(F$3")A$PB81,(F$3")A$PB__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g69798g1203082500149.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g69798g1203082500149.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  D /4# 2(  A$! Q$!_\0
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16W)\TG=L_J2$8PBHQ5DC_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
